Experimental severe Pseudomonas aeruginosa pneumonia and antibiotic therapy in piglets receiving mechanical ventilation

Chest

Volumn 132, Issue 2, 2007, Pages 523-531

  Luna, Carlos M ^a,c   Baquero, Sebastián ^a   Gando, Sebastián ^a   Patrón, Juan Risso ^a   Morato, Joaquín García ^a   Sibila, Oriol ^b   Absi, Rubén ^a   Famiglietti, Angela ^a   Vay, Carlos A ^a   Von Stecher, Florencia ^a   Agustí, Carlos ^a   Torres, Antoni ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF BARCELONA   (Spain)

^c NONE   (Argentina)

Author keywords

Animal; Antibiotic therapy; Mechanical ventilation; Pseudomonas aeruginosa pneumonia

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; HYPERTHERMIA; HYPOXEMIA; LUNG COMPLIANCE; LUNG LAVAGE; MICROBIOLOGICAL EXAMINATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; OXYGENATION; PIGLET; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; VITAL SIGN;

EID: 34548024190     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0185     Document Type: Article

References (21)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee. JAMA 1995; 274:639-644
2. Goldstein I, Bughalo MT, Marquette CH, et al. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001; 163:958-964
3. Crouch Brewer S, Wunderink RG, et al. Ventilator associated pneumonia due to Pseudomona aeruginosa. Chest 1996; 109:1019-1029
4. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-884
5. Marquette CH, Wermert D, Wallet F, et al. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999; 115:200-209
6. Tonnellier M, Ferrari F, Goldstein I, et al. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 2005; 102:995-1000
7. Elman M, Goldstein I, Marquette CH, et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002; 97:199-206
8. Marquette CH, Mensier E, Copin MC, et al. Experimental models of tracheobronchial stenoses: a useful tool for evaluating airway stents. Ann Thorac Surg 1995; 60:651-656
9. Goldstein I, Wallet F, Robert J, et al. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 2002; 165:171-175
10. Flanders SA, Stein J, Shochat G, et al. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med 2004; 116:529-535
11. Bergeron Y, Ouellet N, Deslauriers A, et al. Cytokine kinetics and other factors in response to pneumococcal pulmonary infection in mice. Infect Inmun 1998; 66:912-922
12. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
13. Garrard CS, A'Court CD. The diagnosis of pneumonia in the critically ill. Chest 1995; 108:15S-25S
14. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
15. Marquette CH, Copin MC, Wallet F, et al. Relationship between microbiologic and histologic features in bacterial pneumonia. Am J Respir Crit Care Med 1996; 154:1784-1787
16. Prats E, Dorca J, Pujol M, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J 2002; 19:944-951
17. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27:158-164
18. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
19. Rinaldo JE, Rogers RM. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med 1982; 306:900-909
20. Zimmerman GA, Renzetti AD, Hill HR. Granulocyte adherence in pulmonary and systemic arterial blood samples from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1984; 129:798-804
21. El-Solh AA, Okada M, Pietrantoni C, et al. Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy. Intensive Care Med 2004; 14:1914-1920